ANTI-TRAUMATIC GRAN MAL SEIZURES (GTCS)

Framework Code: SCF-PCRB-FDA-N6K7-EPI-GMS-0002

Classification: Translational Pharmacology Mapping (MoA → Approved Drug → SCF Synergy Integration)

I. OBJECTIVE

To map each PCR Braid mechanistic layer (Preventative, Curative, Restorative) to:

• Closest FDA-approved / clinically validated drugs
• Mechanistically aligned pre-approved (clinical-stage) agents
• SCF-based synergistic augmentation rationale

II. PREVENTATIVE LAYER (P) — DRUG MAPPING

Goal:

Raise seizure threshold, stabilize membrane, prevent initiation

P1 — Kv7 Activation (Membrane Stabilization)

Synergistic Augmentation

• Combine with Naviquel-7 (partial Kv7 activation)
• Add mitochondrial support agents (see R layer)

Rationale

• Directly increases M-current → raises firing threshold
• Synergy:

Kv7_{activation} + Nav_{modulation} \Rightarrow Stable\ subthreshold\ membrane

P2 — Sodium Channel Stabilization (Baseline)

Synergistic Augmentation

• Low-dose lacosamide + Naviquel-7 selective Nav1.6 targeting

Rationale

• Lacosamide enhances slow inactivation
• Naviquel-7 targets persistent/resurgent currents

→ Complementary gating control

P3 — Redox Stabilization

Synergistic Augmentation

• NAC + Naviquel-7 electron flow stabilization

Rationale

• ROS increases excitability via channel oxidation
• NAC restores redox balance → stabilizes ion channels

III. CURATIVE LAYER (C) — DRUG MAPPING

Goal:

Rapid seizure termination and propagation collapse

C1 — Fast Nav Channel Blockade

Synergistic Augmentation

• Acute phenytoin + Naviquel-7

Rationale

• Phenytoin: fast broad blockade
• Naviquel-7: selective Nav1.6 + Kv7 support

→ Fast + precise suppression synergy

C2 — GABAergic Enhancement

Synergistic Augmentation

• Diazepam (rescue) + Naviquel-7

Rationale

• Immediate inhibitory boost
• Naviquel-7 stabilizes membrane → prevents rebound

C3 — Calcium Burst Suppression

Synergistic Augmentation

• Combine with Nav1.6 blockade

Rationale

• Ca²⁺ drives burst propagation
• Dual Na⁺ + Ca²⁺ suppression collapses ictal wave

C4 — Synaptic Excitation Reduction

Synergistic Augmentation

• Levetiracetam + Naviquel-7

Rationale

• Reduces neurotransmitter release
• Complements ion-channel-level suppression

IV. RESTORATIVE LAYER (R) — DRUG MAPPING

Goal:

Neuro-cognitive recovery + anti-epileptogenesis

R1 — Mitochondrial Energy Restoration

Synergistic Augmentation

• CoQ10 + Naviquel-7

Rationale

• Restores ATP → supports Na⁺/K⁺ pumps
• Enhances electron flow normalization

R2 — Neuroinflammation Suppression

Synergistic Augmentation

• Anti-inflammatory + ion stabilization

Rationale

• Cytokines increase excitability
• Reducing inflammation lowers recurrence risk

R3 — Synaptic Plasticity Reset

Synergistic Augmentation

• Memantine + Naviquel-7

Rationale

• Prevents excitotoxic remodeling
• Supports cognitive recovery

R4 — GABAergic Rebalancing

Synergistic Augmentation

• Low-dose valproate + Kv7 activation

Rationale

• Restores inhibitory tone postictally
• Prevents rebound hyperexcitability

V. FULL SCF-PCR BRAID DRUG STACK

Integrated Multi-Layer Stack

VI. SYNERGISTIC AUGMENTATION MATRIX

Key Synergy Axes

VII. SCF 1+1⇒3 SYNERGY EXAMPLES

Example 1 — Nav + Kv7

• Lacosamide + Ezogabine

→ Stable membrane

• Naviquel-7

→ Precision + amplification → seizure prevention

Example 2 — Acute Rescue

• Diazepam + Phenytoin

→ Rapid suppression

• Naviquel-7

→ Reduced recurrence + improved recovery

Example 3 — Recovery Phase

• CoQ10 + Memantine

→ Energy + synaptic reset

• Naviquel-7

→ Neuro-cognitive realignment

VIII. CLINICAL TRANSLATION STRATEGY

Use Case: Acute + Chronic Integration

IX. SAFETY & OPTIMIZATION CONSIDERATIONS

Risk Mitigation

• Avoid:
• Excessive Na⁺ blockade (cardiac risk)
• Monitor:
• CNS depression (benzodiazepines)
• Optimize:
• Dose balancing via SCF synergy

X. INTEGRATED SCF LOGIC SUMMARY

FDA-aligned drug mapping + SCF synergy augmentation → full-spectrum seizure control (prevention + interruption + recovery)

MASTER REGISTRY INDEX

• SCF-PCRB-FDA-N6K7-EPI-GMS-0002 — PCR Braid Drug Mapping
• SCF-PCRB-N6K7-EPI-GMS-0001 — PCR Braid Strategy
• SCF-CMMA-EPI-GMS-0001 — Consolidated MoA/MeA Table
• SCF-ADP-N6K7-EPI-GMS-0001 — API Discovery Profile
• SCF-MOGEM-EPI-GMS-0001 — Electrophysiological Modeling
• SCF-SEF-MD-0001 — Synergistic Evaluation Framework

If you want next, I can generate:

• Exact dosing algorithms (PCR layer-weighted)
• Drug–drug interaction modeling
• Clinical trial design for combination therapy
• AI-driven adaptive PCR treatment system